Journal article

Deferred treatment with sofosbuvir-velpatasvir-voxilaprevir for patients with chronic hepatitis C virus who were previously treated with an NS5A inhibitor: an open-label substudy of POLARIS-1

Marc Bourliere, Stuart C Gordon, Eugene R Schiff, Tram T Tran, Natarajan Ravendhran, Charles S Landis, Robert H Hyland, Luisa M Stamm, Jie Zhang, Hadas Dvory-Sobol, G Mani Subramanian, Diana M Brainard, John G McHutchison, Lawrence Serfaty, Alex J Thompson, Thomas E Sepe, Michael P Curry, K Rajender Reddy, Michael P Manns

The Lancet Gastroenterology & Hepatology | ELSEVIER INC | Published : 2018